Novoeight®

Novoeight® is an Antihemophilic Factor (Recombinant) indicated for use in adults and children with hemophilia A for:

- Control and prevention of bleeding
- Perioperative management
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

*Novoeight is not indicated for the treatment of von Willebrand disease.

For indications, dosing and other information, please refer to the prescribing information.

Novoeight® ‐ NovoNordisk

Size:
250 unit, 4 mL vial
NDC #:
00169-7825-01
Download:
PI
Size:
500 unit, 4 mL vial
NDC #:
00169-7850-01
Download:
PI
Size:
1000 unit, 4 mL vial
NDC #:
00169-7810-01
Download:
PI
Size:
1500 unit, 4 mL vial
NDC #:
00169-7815-01
Download:
PI
Size:
2000 unit, 4 mL vial
NDC #:
00169-7820-01
Download:
PI
Size:
3000 unit, 4 mL vial
NDC #:
00169-7830-01
Download:
PI